[Skip to Navigation]
Comment & Response
December 4, 2019

Clinical Considerations Prior to Transition From Triple Antithrombotic Therapy to Dual Antithrombotic Therapy—Reply

Author Affiliations
  • 1Duke Clinical Research Institute, Durham, North Carolina
  • 2Amsterdam UMC, Academic Medical Center, Amsterdam, the Netherlands
JAMA Cardiol. 2020;5(1):111-112. doi:10.1001/jamacardio.2019.4551

In Reply We recently performed a network meta-analysis evaluating the safety and efficacy of 4 antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention using data from randomized clinical trials.1 Sulaica et al raise 3 relevant issues related to our analysis: (1) clinical presentation with (un)stable plaque; (2) timing of aspirin discontinuation; and (3) sex differences in safety and efficacy.

Add or change institution